Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Abbott 126.57 -1.59 -1.24% 12.44%
Align Technology 489.56 -35.07 -6.68% -12.17%
Anika Therapeutics 33.64 -0.57 -1.67% -15.79%
Arrowhead Research 54.13 -3.68 -6.37% -34.11%
Baxter International 85.86 0.12 0.14% 8.92%
BioScrip 22.65 -1.68 -6.91% 19.65%
Boston Scientific 44.22 -0.64 -1.43% 21.92%
CryoLife 18.22 -0.93 -4.86% -24.65%
EDAP TMS 6.67 0.26 4.06% -2.34%
Edwards Lifesciences 115.83 -2.43 -2.05% 31.76%
GenMark Diagnostics 24.04 0 0% 169.66%
Haemonetics 51.55 -1.14 -2.16% -59.81%
Heron Therapeutics 8.14 -0.56 -6.44% -54.65%
J&J 167.10 -0.74 -0.44% 2.65%
Mesa Laboratories 295.82 -0.33 -0.11% 1.31%
Merit Medical Systems 55.71 -2.10 -3.63% -0.39%
Nektar Therapeutics 11.72 -0.38 -3.14% -31.94%
Oxford Immunotec Global 21.95 -0.04 -0.18% 80.07%
Providence Service 155.58 0 0% 158.61%
Surmodics 45.03 -2.03 -4.31% 1.05%
Stryker 260.48 -6.23 -2.34% 7.61%
Trinity Biotech 1.35 -0.04 -2.53% -67.86%

Indexes Price Day Year
NASDAQ 14507 -386.86 -2.60% 9.92%
US2000 2096 -66.23 -3.06% -2.55%

Surmodics
Surmodics, Inc. is a provider of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The Company operates through two segments: Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices, as well as drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that includes coronary, peripheral, neurovascular and structural heart, among others. The IVD segment designs, develops and manufactures component products and technologies for diagnostic immunoassay, as well as molecular tests and biomedical research applications, with products that include protein stabilization reagents, substrates, surface coatings and antigens.